Article
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.
Oncogene - 25 Mar 2004
Willis Amy, Jung Eun Joo, Wakefield Therese, Chen Xinbin
Abstract excerpt
Mutation of the p53 tumor suppressor gene is the most common genetic alteration in human cancer. A majority of these mutations are missense mutations in the DNA-binding domain. As a result, the mutated p53 gene encodes a full-length protein incapable of transactivating its target genes. In addition to this loss of function, mutant p53 can have a dominant negative effect over wild-type p53 and/or gain of function...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
